Public Employees Retirement System of Ohio Buys Shares of 9,185 DaVita Inc. $DVA

Public Employees Retirement System of Ohio purchased a new position in DaVita Inc. (NYSE:DVA) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 9,185 shares of the company’s stock, valued at approximately $2,043,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Value Investment Professionals LLC grew its stake in shares of DaVita by 2.0% in the second quarter. Value Investment Professionals LLC now owns 2,501 shares of the company’s stock worth $556,000 after acquiring an additional 50 shares during the period. Kesler Norman & Wride LLC lifted its position in DaVita by 0.8% during the first quarter. Kesler Norman & Wride LLC now owns 6,816 shares of the company’s stock valued at $1,048,000 after purchasing an additional 55 shares during the period. Gen Wealth Partners Inc boosted its holdings in DaVita by 10.0% in the fourth quarter. Gen Wealth Partners Inc now owns 880 shares of the company’s stock worth $100,000 after purchasing an additional 80 shares during the last quarter. NewEdge Advisors LLC grew its position in DaVita by 20.8% in the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock worth $78,000 after purchasing an additional 88 shares during the period. Finally, Orion Porfolio Solutions LLC lifted its holdings in shares of DaVita by 4.4% during the 4th quarter. Orion Porfolio Solutions LLC now owns 2,360 shares of the company’s stock valued at $268,000 after buying an additional 99 shares during the period. 90.12% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

DVA has been the subject of several research analyst reports. Weiss Ratings raised DaVita from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. UBS Group increased their target price on DaVita from $235.00 to $270.00 and gave the company a “buy” rating in a report on Friday, July 10th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $265.00 price target on shares of DaVita in a research note on Wednesday, August 5th. Zacks Research lowered shares of DaVita from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. Finally, Truist Financial lowered their price objective on shares of DaVita from $250.00 to $215.00 and set a “hold” rating on the stock in a research note on Friday, August 7th. Four analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, DaVita currently has an average rating of “Hold” and a consensus price target of $221.75.

DaVita Stock Down 0.1%

NYSE DVA opened at $183.87 on Monday. DaVita Inc. has a 52 week low of $101.00 and a 52 week high of $247.49. The company has a market capitalization of $11.73 billion, a P/E ratio of 15.05, a price-to-earnings-growth ratio of 0.48 and a beta of 0.83. The stock’s 50-day moving average price is $208.62 and its 200-day moving average price is $184.53.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $4.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.88 by $0.14. DaVita had a negative return on equity of 217.63% and a net margin of 6.05%.The company had revenue of $3.55 billion during the quarter, compared to the consensus estimate of $3.50 billion. During the same period in the previous year, the company posted $2.95 EPS. The firm’s revenue was up 5.2% on a year-over-year basis. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Research analysts anticipate that DaVita Inc. will post 14.57 EPS for the current year.

Insider Activity

In related news, insider Kathleen Waters sold 15,405 shares of DaVita stock in a transaction on Monday, June 15th. The shares were sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the transaction, the insider owned 109,194 shares in the company, valued at approximately $22,756,029.60. The trade was a 12.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.90% of the stock is currently owned by company insiders.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.